Precision System Science Co., Ltd. (TYO:7707)
240.00
+2.00 (0.84%)
Feb 16, 2026, 3:30 PM JST
Precision System Science Revenue
Precision System Science had revenue of 1.32B JPY in the quarter ending September 30, 2025, with 22.17% growth. This brings the company's revenue in the last twelve months to 4.93B, up 23.74% year-over-year. In the fiscal year ending June 30, 2025, Precision System Science had annual revenue of 4.69B with 17.92% growth.
Revenue (ttm)
4.93B
Revenue Growth
+23.74%
P/S Ratio
1.32
Revenue / Employee
32.66M
Employees
151
Market Cap
6.53B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 4.69B | 713.00M | 17.92% |
| Jun 30, 2024 | 3.98B | -1.30B | -24.61% |
| Jun 30, 2023 | 5.28B | -2.16B | -29.00% |
| Jun 30, 2022 | 7.43B | -1.86B | -20.05% |
| Jun 30, 2021 | 9.30B | 4.23B | 83.50% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Takeda Pharmaceutical Company | 4.46T |
| Otsuka Holdings | 2.47T |
| Chugai Pharmaceutical | 1.26T |
| HOYA Corporation | 915.21B |
| Nippon Chemiphar | 32.52B |
| Kohjin Bio | 5.07B |
| WDB coco | 4.98B |
| MedRx | 120.00M |